BioCentury | Feb 24, 2017
Financial News

Modus Therapeutics completes venture financing

...AM (Stockholm, Sweden) raised SEK32 million ($3.6 million) in a venture round with existing investors KDev Investments...
BioCentury | Mar 24, 2014
Financial News

Rosetta Capital Ltd. financial update

...recently in 2012, Rosetta paid SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
BioCentury | Mar 24, 2014
Finance

Rosetta (mile)stones

...Most recently, the firm paid SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
BioCentury | Mar 20, 2014
Financial News

Rosetta Capital buys part of pharma venture portfolio

...recently in 2012, Rosetta paid SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
BioCentury | Mar 18, 2013
Financial News

Karolinska Development financial update

...Rosetta Capital (London, U.K.) paid SEK220 million ($34.4 million) to acquire a minority stake in KDev Investments...
BioCentury | Jan 14, 2013
Finance

Rosetta's Nordic preferences

...will likely be the only such arrangement for Karolinska. Karolinska created a private holding company, KDev Investments...
BioCentury | Dec 24, 2012
Financial News

Karolinska Development, Rosetta Capital Ltd. financial update

...firm Rosetta Capital will pay SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
BioCentury | Dec 22, 2012
Financial News

Rosetta syndicate acquiring stake in Karolinska companies

...Rosetta Capital Ltd. will pay SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
Items per page:
1 - 8 of 8
BioCentury | Feb 24, 2017
Financial News

Modus Therapeutics completes venture financing

...AM (Stockholm, Sweden) raised SEK32 million ($3.6 million) in a venture round with existing investors KDev Investments...
BioCentury | Mar 24, 2014
Financial News

Rosetta Capital Ltd. financial update

...recently in 2012, Rosetta paid SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
BioCentury | Mar 24, 2014
Finance

Rosetta (mile)stones

...Most recently, the firm paid SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
BioCentury | Mar 20, 2014
Financial News

Rosetta Capital buys part of pharma venture portfolio

...recently in 2012, Rosetta paid SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
BioCentury | Mar 18, 2013
Financial News

Karolinska Development financial update

...Rosetta Capital (London, U.K.) paid SEK220 million ($34.4 million) to acquire a minority stake in KDev Investments...
BioCentury | Jan 14, 2013
Finance

Rosetta's Nordic preferences

...will likely be the only such arrangement for Karolinska. Karolinska created a private holding company, KDev Investments...
BioCentury | Dec 24, 2012
Financial News

Karolinska Development, Rosetta Capital Ltd. financial update

...firm Rosetta Capital will pay SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
BioCentury | Dec 22, 2012
Financial News

Rosetta syndicate acquiring stake in Karolinska companies

...Rosetta Capital Ltd. will pay SEK220 million ($33 million) to acquire a minority stake in KDev Investments...
Items per page:
1 - 8 of 8